Exane Derivatives’s Ocular Therapeutix OCUL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,496	Closed	-$19.3K	–	1055
2021 Q2	$19.3K	Hold	1,496	–	–	﹤0.01%	691
2021 Q1	$24.5K	Hold	1,496	–	–	0.01%	540
2020 Q4	$31K	Buy	+1,496	New	+$31K	0.01%	483